IGM Biosciences (STU:1K0) FCF Yield % : -221.28 (As of Mar. 23, 2025)

View and export this data going back to 2019. Start your Free Trial

What is IGM Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, IGM Biosciences's Trailing 12-Month Free Cash Flow is €-146.98 Mil, and Market Cap is €66.07 Mil. Therefore, IGM Biosciences's FCF Yield % for today is -221.28%.

The historical rank and industry rank for IGM Biosciences's FCF Yield % or its related term are showing as below:

STU:1K0' s FCF Yield % Range Over the Past 10 Years
Min: -222.38 Med: -28.6 Max: -0.52
Current: -221.28

During the past 8 years, the highest FCF Yield % of IGM Biosciences was -0.52%. The lowest was -222.38%. And the median was -28.60%.

STU:1K0's FCF Yield % is ranked worse than
92.74% of 1501 companies
in the Biotechnology industry
Industry Median: -14.39 vs STU:1K0: -221.28

IGM Biosciences's FCF Margin % for the quarter that ended in Dec. 2024 was -8,670.74%.

IGM Biosciences FCF Yield % Historical Data

The historical data trend for IGM Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGM Biosciences FCF Yield % Chart

IGM Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-3.07

-14.94

-2.38

-40.99

-42.39

IGM Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-39.63	-33.17	-39.68	-15.52	-38.08

Competitive Comparison of IGM Biosciences's FCF Yield %

For the Biotechnology subindustry, IGM Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IGM Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IGM Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where IGM Biosciences's FCF Yield % falls into.

IGM Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

IGM Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-151.7	/	357.906
	=	-42.39%

IGM Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-34.076	*	4	/	357.906
	=	-38.08%

IGM Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

IGM Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of IGM Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

IGM Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGM Biosciences Inc (STU:1K0) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

IGMS:USA

Address

325 East Middlefield Road, Mountain View, CA, USA, 94043

Website

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.

IGM Biosciences Headlines

No Headlines